📋 FDA Reference

Liverty™ TIPS Stent Graft

Bard Peripheral Vascular, Inc.

Contact Bard Peripheral Vascular, Inc. ↗ Compare similar devices

FDA Clearance Information

Pathway ? PMA
Number ? P250050 ↗
Decision Date ? September 25, 2026
Product Code ? MIR Shunt, Portosystemic, Endoprosthesis
Device Class ? Class 3
Evidence ? 0 studies

FDA-Cleared Indications

Approval for the Liverty™ TIPS Stent Graft. The device is indicated for the treatment of complications of portal hypertension

Clinical Applications

Frequently Asked Questions

Questions about Liverty™ TIPS Stent Graft? Contact Bard Peripheral Vascular, Inc. ↗.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you